SCHEMBL6982316

SCHEMBL6982316

Nc1ccc(-c2ccc(-c3nc(N)nc(N)n3)cc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.64
NPC1 O15118 4/20 0.64
ADORA3 P0DMS8 2/20 0.62
ADORA2A P29274 2/20 0.62
ADORA2B P29275 2/20 0.62
ADORA1 P30542 2/20 0.62
POLB P06746 1/20 0.62
ALDH1A1 P00352 5/20 0.55
TP53 P04637 2/20 0.55
CYP3A4 P08684 2/20 0.55
TDP1 Q9NUW8 2/20 0.55
HPGD P15428 5/20 0.54
MEN1 O00255 5/20 0.54
KMT2A Q03164 5/20 0.54
MAPT P10636 4/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
HSD17B10 Q99714 2/20 0.54
KDM4E B2RXH2 2/20 0.54
IKBKB O14920 1/20 0.47
BRAF P15056 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3420215 0.97 RAB9A (0.67) RAB9ANPC1ADORA3ADORA2AADORA2B
SCHEMBL28880529 0.89 RAB9A (0.76) RAB9ANPC1ADORA3ADORA2AADORA2B
SCHEMBL31633459 0.89 ALDH1A1 (0.69) RAB9ANPC1ADORA3ADORA2AADORA2B
SCHEMBL8425035 0.87 MEN1 (0.62) RAB9ANPC1ADORA3ADORA2AADORA2B
Methane SCHEMBL28329643 0.84 MEN1 (0.60) RAB9ANPC1ADORA3ADORA2AADORA2B
SCHEMBL6334237 0.83 ADORA1 (0.82) RAB9ANPC1ADORA3ADORA2AADORA2B
SCHEMBL6977514 0.83 ADORA1 (0.91) RAB9ANPC1ADORA3ADORA2AADORA2B
SCHEMBL18057759 0.83 ADORA1 (0.82) RAB9ANPC1ADORA3ADORA2AADORA2B
Benzoguanamine SCHEMBL28092497 0.81 ADORA2A (0.86) RAB9ANPC1ADORA3ADORA2AADORA2B
SCHEMBL6977760 0.81 RAB9A (0.59) RAB9ANPC1ADORA3ADORA2AADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1037886-B1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LAB (US) 2003-05-02 EP claimed
US-6150362-A ADMINISTERING 1,3,5-SUBSTITUTED TRIAZINE COMPOUNDS TO THE PATIENT SUFFERING FROM ANGIOGENIC DISEASES ABBVIE INC. 2000-11-21 US claimed
EP-1037886-A1 TRIAZINE ANGIOGENESIS INHIBITORS Abbott Laboratories (US) 2000-09-27 EP claimed
WO-1999031088-A1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 1999-06-24 WO claimed
EP-1037886-B1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LAB (US) 2003-05-02 EP disclosed
US-6288228-B1 DIAMINOTRIAZINE DERIVATIVES ABBOTT LABORATORIES 2001-09-11 US disclosed
US-6150362-A ADMINISTERING 1,3,5-SUBSTITUTED TRIAZINE COMPOUNDS TO THE PATIENT SUFFERING FROM ANGIOGENIC DISEASES ABBVIE INC. 2000-11-21 US disclosed